Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2006;82:649-657; doi:10.1136/pgmj.2006.047340
Copyright © 2006 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piscopo, T V
Right arrow Articles by Mallia, A C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piscopo, T V
Right arrow Articles by Mallia, A C

REVIEW

Leishmaniasis

T V Piscopo , A C Mallia

Sir Temi Zammit Infectious Disease Unit, St Luke’s Hospital, Guardamangia, Malta

Correspondence to:
Correspondence to:
T V Piscopo
Sir Temi Zammit Infectious Disease Unit, St Luke’s Hospital, Guardamangia Hill, Guardamangia, MSD 09, Malta;tonio.piscopo{at}gov.mt

Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity of this infection, and new diagnostic tests that are helping better diagnosis, especially in resource-poor areas. Other important aspects discussed include the potential for newer oral treatment to change the way this disease is managed; leishmania–HIV coinfection and groups at risk; and the development of an effective vaccine.


Abbreviations: PCR, polymerase chain reaction; PKDL, post-kala azar dermal leishmaniasis; Sb(V), pentavalent antiminy; Th, T helper; TNF{alpha}, tumour necrosis factor {alpha}; INF{gamma}, interferon {gamma}

Keywords: Leishmania; antimonial; amphotericin; miltefosine; HIV







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 The Fellowship of Postgraduate Medicine